Association of GnRH Agonist Pretreatment with Reproductive Outcomes in Women ≥35 years with Diminished Ovarian Reserve Undergoing Frozen Embryo Transfer: A Large Retrospective Cohort Study

GnRH激动剂预处理与≥35岁卵巢储备功能减退女性冷冻胚胎移植后生殖结局的关系:一项大型回顾性队列研究

阅读:1

Abstract

PURPOSE: This study aimed to assess whether different endometrial preparation regimens-natural cycle (NC), hormone replacement therapy (HRT), and gonadotropin-releasing hormone agonist pretreatment followed by HRT (GnRH-a + HRT)-are associated with differences in reproductive and perinatal outcomes among women with diminished ovarian reserve undergoing frozen embryo transfer (FET), and to evaluate whether age (<35 vs ≥35 years) modifies these associations. PATIENTS AND METHODS: A total of 4629 women with DOR, defined as anti-Müllerian hormone (AMH) <1.2 ng/mL and/or antral follicle count (AFC) <5, undergoing their first autologous FET between 2016 and 2024. Endometrial preparation protocols included natural cycle (NC), hormone replacement therapy (HRT), or gonadotropin-releasing hormone agonist (GnRH-a) pretreatment followed by HRT. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were applied to adjust for baseline differences. RESULTS: GnRH-a pretreatment before HRT was associated with improved live birth and clinical pregnancy compared with HRT alone, particularly among older women. No significant differences were observed between natural cycle and HRT. Perinatal outcomes among singleton live births were generally comparable across protocols. CONCLUSION: GnRH-a pretreatment before HRT may be beneficial for women with diminished ovarian reserve undergoing FET, particularly in those of advanced maternal age.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。